Answers are grounded in this paper and cite their sources.
Human induced pluripotent stem cells (hiPSCs) have revolutionized the field of human disease modeling, with an enormous potential to serve as paradigm shifting platforms for preclinical trials, personalized clinical diagnosis, and drug treatment. In this review, we describe how hiPSCs could transition cardiac healthcare away from simple disease diagnosis to prediction and prevention, bridging the gap between basic and clinical research to bring the best science to every patient.
No takes yet. Share an insight, caveat, or question.
Matsa et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: